Pradeep retweeted
Let me put the issue in perspective @dp_satish
1. Karnataka’s Road Transport Corporations (RTCs), though among the best in the country, have been facing commercial challenges long before the launch of Shakti scheme. Therefore, blaming free travel for women under Shakti for the problems of RTCs is not borne out by facts.
2. In fact, Shakti has resulted in much needed assured cash flow of about Rs 5600 crores per year to the four RTCs. In turn, the RTCs are experiencing better capacity utilisation for the same operational cost, thus the cost per kiolmeter (CPKM) actually reduces.
3. The problems of RTCs have longer history. More than 3/4th of the total cost of RTCs consists of 2 items: fuel & staff. (79.8 % of KSRTC cost, 73.8 % of BMTC cost, 83.3 % of NWKRTC cost and 80.6 % of KKRTC cost is fuel & staff). The cost of these two items has been rising and the fares have not risen over the years. Between 2014 and 2025 the BMTC fares were not increased. Between 2020 and 2025 the fares of KSRTC and other RTCs were not increased.
4. Whereas the diesel prices have increased by about 64% between 2014 & 2026 and 53% between 2020 & 2026. Similarly, staff salaries have risen over the years. When 75% of your cost is fuel and staff and those rise every year, how are the RTCs supposed to make ends meet without fare revision or govt subsidy? You either revise the fares or the state subsidises the RTCs by giving grants. The later method is not sustainable, given the other social policy commitments of the Government. The third alternative is for the RTCs to increase their non-fare revenues. This has been recommended by the M R Sreenivasa Murthy committee a long ago, but not much progress has been achieved.
5. The Government must invest more in public transport as it carries enormous positive externalities. Though over the years investment in RTCs like buying more new buses has come down, since 2023 the Government has introduced / committed to introduce 6034 new buses. In addition, the Government of Karnataka has agreed to deploy 4500 e-buses on GCC under PM-e Drive for BMTC.
6. Of course, the RTCs have been asking for higher reimbursement under Shakti. Government has also been short releasing under student free bus pass schemes. These issues need to be settled in favour of RTCs.
7. To conclude, Shakti is not the problem but a solution. However, this scheme needs to be combined with reasonable reimbursement of the costs and more investment in new buses. With the introduction of smart card the issue of short reimbursement, if any, can be settled.
8. Karnataka’s RTCs are among the few public transport companies in the country that do well. We need to make them perform even better.
Happy Deepavali to all!!
Mismanagement in recent years, and now the free bus rides for women, have all but killed our pride — KSRTC and its sister corporations, NWKRTC, KKRTC and BMTC. The buses are creaking: still breathing, but only just. The staff are demoralised. Unless the government takes a tough, unpopular decision, a great public transport system built over 75 years will collapse. That would be a tragedy.
Free public transport is a fine idea, but only when there is money to pay for it. Personally, I favour free travel for the poor and for students.
In my Malnad region, the private bus network — once among the best and most vibrant anywhere — has become collateral damage. Passenger numbers are dwindling, because of this scheme and other factors, and with them the revenue.
Dorothy. What a movie. Didn’t see half those turns coming. Karthik Subbaraj clearly had fun with this one. Even split his name between the protagonists, Karthi and Subbu!
4
95
Pradeep retweeted
Safed jersey se vida le raha hoon, lekin usse judi yaadon se kabhi nahi… 🇮🇳❤️
Jab pehli baar Bharat ki Test jersey pehni thi, tab sirf ek sapna tha — apne desh ke liye kuch kar dikhane ka..
Uske baad har wicket, har sangharsh, har chot aur har comeback ne mujhe kuch na kuch sikhaya.
Test cricket mere liye sirf ek format nahi, meri zindagi ka ek behad khaas hissa raha hai.
Aaj bhaari dil aur anginat khoobsurat yaadon ke saath main Test cricket se retirement lene ka faisla kar raha hoon.
Is safar mein mera saath dene wale har teammate, coach, family aur un karodon Bharatiyon ka dil se shukriya, jinhone achhe aur mushkil dono waqt mein mujh par bharosa banaye rakha..
BCCI aur Cricket Association of Bengal (CAB) ka bhi dil se shukriya, jinhone mere talent par bharosa kiya, mujhe aage badhne ke mauke diye aur mere cricket ke safar mein ek aham bhoomika nibhayi. Aapka saath aur vishwas mere liye hamesha khaas rahega.
Maidan par meri aakhri Test ball bhale hi fenki ja chuki ho, lekin Bharat ke liye khelne ka garv hamesha mere dil mein zinda rahega.
Shukriya, Test Cricket. ❤️
Aapka Shami 🇮🇳
#Mdshami11 #Mdshami #TestCricket #Retirement
Across the courtyard, a shower of figs.
Alone, a shower of ixora blossoms.
Even in the midday heat, it feels like midnight,
with pure moonlight all around.
La la la…
Now, which song is this?
34
Pradeep retweeted
ADNOC announced the signing of a long-term Sales and Purchase Agreement with Gujarat Energy to supply LNG to India from the international gas portfolio of XRG, ADNOC’s international investment company.
Under the agreement, Gujarat Energy will receive up to 4 million tonnes of LNG over ten years, starting in 2028. The agreement is ADNOC’s 5th LNG supply agreement in India. #OOTT
Well, the medical community is asking questions. And I guess rightly so.
Rs 85,000 for Temple. What does an ordinary person actually get?
@deepigoyal, here are the questions a buyer would ask. I'm a doctor with 30+ years of practice, and I'd like straight answers.
1. What do I do with the numbers?
Say my BrainFlow is low today. Or my Span is 40. What exactly should I do tomorrow? Sleep more? Exercise less or more? See a doctor? I can't find a single actionable on your site, in your studies or in your "foundational research."
2. Why should I care about Span and Entropy?
Your homepage says Span shows "how well your body is doing across a wide range of systems." Medicine has no such single number. Entropy and Span are Temple's own scores. The papers you cite for them are a hypothesis paper and an 11-man cycling study. I found no study showing that tracking or improving these numbers extends healthspan or lifespan.
3. Is this a breakthrough in longevity?
Not on the evidence shown. Your studies on BrainFlow, still "in peer review," tested healthy young people in short posture and exercise tests. It's an interesting start. It isn't a proven health or lifespan tool, and your own research page says associations don't show that raising brain flow prolongs life.
4. What does the contract say?
Your terms say it's not a medical device and that Temple makes no representation about the validity, accuracy or reliability of its data. Use is at the buyer's risk. Big promise in the marketing, none in the fine print.
5. What if I'm unhappy?
You say returns are 14-day, no-questions-asked. The terms say: reason and proof required, refund may be partial after inspection, shipping and taxes non-refundable, decisions final, and legal action against "invalid" claims.
6. What else gives me heart rate and recovery?
Any decent watch does.
A BP monitor, the right blood tests and a good watch cost a fraction of this.
What actually protects the brain and extends healthy life is known for years, cheap and needs no sensor: exercise, sleep, BP and sugar control, social connection, learning new things.
Early-stage science is fine.
But please tell buyers plainly, on the product page: "This device can't tell you whether you are healthy or ill, and no study yet shows it helps you live longer or better."
Mocking doctors won't answer these questions. A clear product page will.
3
130
Pradeep retweeted
Temple vs LiverDoc saga is making me think that maybe the real reason why India has not been able to produce global consumer products is that we suck at marketing. It’s pretty obvious what Temple is and is not, they’ve done a really poor job of anchoring and distilling their storytelling which should’ve been clear from the beginning. I doubt a brand of this stature will want to deliberately defraud people, but a lack of rabid obsession for accuracy, balance, integrity, and clarity in storytelling is disastrous for a company in consumer science.
All this could’ve been avoided if Temple had settled their product marketing and science storytelling before announcing the product. If you remember Deepinder’s first few tweets, confusion has been their problem from day 1. I hope they take some time to clearly frame — for themselves first of all — what Temple really is and what it isn’t. And then hire a team of solid science journalists and consumer marketers to own the narrative. Deepinder should delegate on this front.
As for LiverDoc, so much respect for his commitment. It’s not easy to beef with billionaires in public view. It’s always a win for consumers for such heat to exist, especially in markets as sensitive as science (or science adjacent).
On paper, few leaders are better qualified to run an economy than a former IMF economist and finance minister. I guess this is a reminder that expertise is no substitute for independent institutions.
Paraguay's president resigns following a crisis over a bank collapse, leaving millions of customers unable to access their money cnn.it/4Ach622
32
Glenn Maxwell retires from international cricket having produced some of the most astonishing feats in modern cricket, all the while revealing his vulnerabilities in the moments in between cricinfo.com/story/glenn-max…
To love Kannada is natural. To love it extravagantly is an art.
#kananada #KannadaRajyotsava
#kannadamaxxing
Pradeep retweeted
BREAKING: DoorDash just agreed to buy Instacart for $17 billion. Here's what that means for customers and shoppers. apnews.com/article/doordash-…
Lovely piece. Extra marks for the headline.
Also, Justin definitely wasn't twice Ashley's age.
#BethlehemKudumbaUnit's record success and charms are no reason to ignore questions about the sidelining and erasure of "older women" in Indian film industries and films. Read my column in The Economic Times ⬇️
"If Romeo can love, why must Juliet die?"
economictimes.indiatimes.com…






















